Barclays’s Equillium EQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-104
Closed -$87 5331
2024
Q3
$87 Buy
+104
New +$87 ﹤0.01% 5188
2021
Q4
Sell
-15
Closed 4264
2021
Q3
$0 Hold
15
﹤0.01% 4807
2021
Q2
$0 Buy
+15
New +$95 ﹤0.01% 4922
2020
Q4
Sell
-100
Closed -$1K 4958
2020
Q3
$1K Buy
+100
New +$810 ﹤0.01% 5141
2019
Q3
Sell
-96
Closed -$1K 6804
2019
Q2
$1K Sell
96
-1,379
-93% -$8.67K ﹤0.01% 6834
2019
Q1
$12K Buy
1,475
+1,325
+883% +$10.9K ﹤0.01% 6509
2018
Q4
$1K Buy
+150
New +$2.08K ﹤0.01% 6789

Other funds holding EQ

Barclays's EQ Position: Q4 2024 in Review

Barclays sold out of Equillium (EQ) in Q4 2024, closing a stake of 104 shares — an estimated $87 sold.

Barclays first reported a position in EQ in Q4 2018 and held it in 7 quarters. The position peaked at $12K in Q1 2019. 26 funds tracked by Wall St. Rank hold EQ as of Q4 2024.

  • Barclays reported no remaining Equillium position as of Q4 2024 after selling out during the quarter.
  • Barclays sold 104 Equillium shares in Q4 2024, an estimated $87.
  • Barclays first reported a position in Equillium in Q4 2018 and held it in 7 quarters.
  • Barclays's Equillium position peaked at $12K in Q1 2019.
  • 26 funds tracked by Wall St. Rank held Equillium as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.